Worth reading
62In focus
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
740000
SharesWording
Conditional
How definitive the wording is.Details of issuance or disposal
Monthly exercise status report for stock acquisition rights with an exercise price adjustment clause and completion of the acquisition and cancellation of the remaining stock acquisition rights
発行・処分する株式数740,000Shares
740,000 shares (number of shares delivered during the relevant month)
発行済株式総数
3.3% (exercise ratio related to the exercise limit)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
¥128, ¥129 and ¥132 (exercise prices during the relevant month). Details of the adjustment clause and the floor are Not disclosed
Number of Stock Acquisition Rights
Total issued: 100,000 rights; exercised during the relevant month: 7,400 rights; unexercised at the end of the preceding month: 52,430 rights; remaining after cancellation: 0 rights
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations
Most recent equity financing
Announced on 24 October 2025: issuance by way of a third-party allotment of new shares, the 2025 Series 1 Stock Acquisition Rights (with a fixed exercise price), and the 2025 Series 2 Stock Acquisition Rights (with an exercise price adjustment clause) (amount Not disclosed)
Impact on Business Performance
The Company believes that the impact of the acquisition and cancellation of these stock acquisition rights on its financial results will be immaterial, but will promptly disclose any matter requiring disclosure.
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status report for stock acquisition rights with an exercise price adjustment clause and completion of the acquisition and cancellation of the remaining stock acquisition rights |
| Number of shares to be issued or disposed of | 740,000 shares (number of shares delivered during the relevant month) |
| Dilution Rate | 3.3% (exercise ratio related to the exercise limit) |
| Total number of issued shares | 28,041,392 shares (as of the end of the month preceding the relevant month) → Not disclosed |
| Exercise price | ¥128, ¥129 and ¥132 (exercise prices during the relevant month). Details of the adjustment clause and the floor are Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 100,000 rights; exercised during the relevant month: 7,400 rights; unexercised at the end of the preceding month: 52,430 rights; remaining after cancellation: 0 rights |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | Announced on 24 October 2025: issuance by way of a third-party allotment of new shares, the 2025 Series 1 Stock Acquisition Rights (with a fixed exercise price), and the 2025 Series 2 Stock Acquisition Rights (with an exercise price adjustment clause) (amount Not disclosed) |
| Impact on Business Performance | The Company believes that the impact of the acquisition and cancellation of these stock acquisition rights on its financial results will be immaterial, but will promptly disclose any matter requiring disclosure. |
Items this document does not state (19)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offering
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company stated that it believes the impact of the acquisition and cancellation on its financial results will be immaterial. The document does not state the reason for the acquisition and cancellation itself.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.